Moira Ringo
Director, Consulting
Moira comes to Clarivate with over 20 years of experience in healthcare industry and consulting, and focusses primarily on commercial strategy and market access. Moira began her career in GSK Research and Development after witnessing first-hand the power of medicine for a family member with cancer. At GSK she contributed to clinical development of over 20 assets, including the second approved personalized therapy for oncology. As she observed market access having an increasing role on product uptake, she transitioned to a role optimizing product strategy for newly launched and mature products at GSK, including supporting the launch of the first gene therapy for a rare disease.
Her consulting roles span US and global clinical, market access, and HEOR evidence strategy for advanced oncolytics, diagnostics, medical devices, and cell and gene therapies. She has developed robust channel, product, and market access strategies for the US market. Moira is passionate about uniting diverse client and consulting teams around the common goal of bringing science and technology to patients who need it.
Moira holds a PhD in chemistry from the University of Michigan and an MBA from the Duke Fuqua School of Business with a certificate in health sector management.
Latest news
Clarivate Pulse of the Library 2026 Report Reveals AI Adoption Gaps Across Geographies, Mainland China Advancing Fastest
Organizational readiness, regional differences and evolving priorities are shaping the landscape of AI adoption in libraries London, U.K. September 9, 2026 – Clarivate Plc (NYSE:CLVT), a leading global provider of…
ShanghaiRanking’s Academic Ranking of World Universities 2026 Press Release
The 2026 Academic Ranking of World Universities (ARWU) is released today by ShanghaiRanking Consultancy. Since 2003, ARWU has been presenting the world’s top universities annually based on transparent methodology and…
